Pfizer's dividend yield looks almost too good. Here's why management isn't worried.

Pfizer has a 6.8% yield at a time when the market's yield is roughly 1%: Is there something wrong?

Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?

Pfizer's dividend yield is 7% for a very good reason: investors are worried about the risk of a dividend cut.

Is Pfizer's 7% dividend yield too good to be true? Here's the straight answer

Income seekers shouldn't give up on the stock yet.

Pfizer and the $200 Billion-Dollar Cardiovascular Market

Pfizer's cardiovascular business highlights the intersection of drug pricing, marketing, patents, and competition in the ...

Pfizer: The Post-Pandemic Turnaround Is Already Underway

Pfizer is undervalued, trading just over 8x 2026 earnings, with improving dividend yield and core business fundamentals.
24/7 Wall St.

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

Both Pfizer and Gilead Sciences just flashed the same ominous technical warning while trading below analyst fair value.
24/7 Wall St.

Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Pfizer and Amgen both grew revenue last quarter at nearly the same pace, but the engines driving that growth point toward two very different futures in oncology. One company is collecting cash from ...
Forbes

Pfizer Stock Sinks To 10-Year Low—Why Investors Have Soured On Covid-Era Giant

Pfizer stock’s struggles continued Wednesday, as shares of the healthcare titan dropped to their lowest level since before the Covid-19 pandemic, the latest dubious milestone for the battered stock ...

The Pfizer building incident pits the banner project with a conversion pitfall

Construction delays at MetroLoft's conversion of the Pfizer building could endanger success at the Midtown East project ...